Reoperation After Mitral Valve Repair for Degenerative Disease

Slides:



Advertisements
Similar presentations
Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J
Advertisements

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair?  Jose L. Navia, MD, Nicolas A. Brozzi,
Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 
Characterization and Importance of Air Leak After Lobectomy
A. Marc Gillinov, MD, Tomislav Mihaljevic, MD, Eugene H
Surgical management of secondary tricuspid valve regurgitation: Annulus, commissure, or leaflet procedure?  Jose L. Navia, MD, Edward R. Nowicki, MD,
Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair?  Jose L. Navia, MD, Nicolas A. Brozzi,
Advising complex patients who require complex heart operations
Constantin Stefanidis, MD, Albert M
Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy  Nicholas G. Smedira, MD, Bruce W. Lytle, MD,
Beyond the Aortic Root: Staged Open and Endovascular Repair of Arch and Descending Aorta in Patients With Connective Tissue Disorders  Eric E. Roselli,
Endovascular versus open elephant trunk completion for extensive aortic disease  Eric E. Roselli, MD, Sreekumar Subramanian, MD, Zhiyuan Sun, BS, Jahanzaib.
Mitral Valve Surgery in the Adult Marfan Syndrome Patient
Surgical treatment of pseudoaneurysm of the thoracic aorta
Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm
Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease  Kenji Kuwaki, MD, PhD, Nobuyoshi Kawaharada,
Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F
Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis
Coronary artery bypass grafting in diabetics: A growing health care cost crisis  Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.
Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair  Douglas R. Johnston, MD, A. Marc Gillinov, MD,
Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair
Outcomes of Early Mitral Valve Reoperation in the Medicare Population
A. Marc Gillinov, MD, Sekar Bhavani, MD, Eugene H
Too High for Transplantation
Midterm Results of Mitral Valve Repair: Closed Versus Open Annuloplasty Ring  Dan Spiegelstein, MD, Yaron Moshkovitz, MD, Leonid Sternik, MD, Micha S.
Charles M. Wojnarski, MD, Lars G. Svensson, MD, PhD, Eric E
Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 
Aortic valve replacement: Is valve size important?
A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R
Ahmad Zeeshan, MD, Jay J. Idrees, MD, Douglas R
Atrial fibrillation complicating lung cancer resection
Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E
Long-Term Durability of Bicuspid Aortic Valve Repair
Reduced survival in women after valve surgery for aortic regurgitationEffect of aortic enlargement and late aortic rupture  Monica L. McDonald, MDa, Nicholas.
Farhang Yazdchi, MD, MS, Colleen G
Outcomes of less invasive J-incision approach to aortic valve surgery
Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L
Eugene H. Blackstone, MDa,b, Bruce W. Lytle, MDb 
Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?
Lars G. Svensson, MD, PhD, Gregory D
Distal aortic interventions after repair of ascending dissection: The argument for a more aggressive approach  Eric E. Roselli, MD, Gabriel Loor, MD,
Edward R. Nowicki, MD, MS, Gösta B. Pettersson, MD, PhD, Nicholas G
Outcomes of a Less-Invasive Approach for Proximal Aortic Operations
David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C
John M. Stulak, MD, Joseph A. Dearani, MD, Harold M
Long-term effectiveness of operations for ascending aortic dissections
Impact of Anastomotic Airway Complications After Lung Transplantation
Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes  Ryan K. Kaple, BS, Ross T. Murphy, MD, Linda.
Lars G. Svensson, MD, PhD, Fernando A. Atik, MD, Delos M
Truncus Arteriosus Associated with Interrupted Aortic Arch in 50 Neonates: A Congenital Heart Surgeons Society Study  Igor E. Konstantinov, MD, PhD, Tara.
Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J
Mitral Valve Repair for Degenerative Disease: A 20-Year Experience
Mohammed A Quader, MD, Patrick M McCarthy, MD, A
Is repair preferable to replacement for ischemic mitral regurgitation?
Douglas R. Johnston, MD, Edward G
Endocarditis after mitral valve repair
Survival Advantage and Improved Durability of Mitral Repair for Leaflet Prolapse Subsets in the Current Era  Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff,
Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J
Mitral valve repair with aortic valve replacement is superior to double valve replacement  A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,
Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement 
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Right Minithoracotomy Versus Full Sternotomy for Mitral Valve Repair: A Propensity Matched Comparison  Rüdiger Lange, MD, PhD, Bernhard Voss, MD, Victoria.
Lung Transplantation for Idiopathic Pulmonary Fibrosis
International Normalized Ratio Self-Management Lowers the Risk of Thromboembolic Events After Prosthetic Heart Valve Replacement  Thomas Eitz, MD, Soren.
Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H
Risk of Valve-Related Events After Aortic Valve Repair
Richard J Kaplon, MD, Delos M Cosgrove, MD, A
Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome  Eva Maria B. Delmo Walter, MD, PhD, Richard Van.
Presentation transcript:

Reoperation After Mitral Valve Repair for Degenerative Disease Eric Dumont, MD, A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Joseph F. Sabik, MD, Lars G. Svensson, MD, PhD, Tomislav Mihaljevic, MD, Penny L. Houghtaling, MS, Bruce W. Lytle, MD  The Annals of Thoracic Surgery  Volume 84, Issue 2, Pages 444-450 (August 2007) DOI: 10.1016/j.athoracsur.2007.03.078 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Timing of reoperation for repair failure after mitral valve repair for degenerative disease according to mechanism of failure. Patients having both procedure-related (top line) and valve-related failure (bottom line) appear twice in these graphs. Cumulative distribution of times to failure is shown with each step representing a failure. The median time to failure is the point at which each curve crosses the 50% line. The Annals of Thoracic Surgery 2007 84, 444-450DOI: (10.1016/j.athoracsur.2007.03.078) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Re-repairs versus valve replacement for repair failure after mitral valve repair for degenerative disease by date of reoperation. Solid circles represent means by yearly groupings and the solid line is a trend line. (A) Overall results. (B) Results stratified by mechanism for repair failure. Patients experiencing both procedure-related (top line, filled circles) and valve-related mechanisms (bottom line, open circles) of failure appear in both strata. The Annals of Thoracic Surgery 2007 84, 444-450DOI: (10.1016/j.athoracsur.2007.03.078) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Freedom from reoperation after mitral valve re-repair (line). Each solid circle is a reoperation, vertical bars are asymmetric confidence limits equivalent to ± 1 standard error, and numbers in parentheses patients are remaining at risk. The Annals of Thoracic Surgery 2007 84, 444-450DOI: (10.1016/j.athoracsur.2007.03.078) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 (A) Risk-unadjusted overall survival after mitral valve (MV) reoperation for repair failure. Each open circle represents a death, vertical bars are asymmetric confidence limits (CLs) equivalent to ± 1 standard error, and numbers in parentheses are patients at risk. Solid lines are parametric estimates enclosed in CLs equivalent to ±1 standard error (dashed line). (B) Unadjusted survival stratified by approach to reoperation (repair [top set of lines] versus replacement (bottom set of lines]). Filled circles (repair) and open triangles (replacement) represent a death, vertical bars are asymmetric confidence limits (CLs) equivalent to ±1 standard error, and numbers in parentheses are patients at risk. Solid lines are parametric estimates enclosed in CLs equivalent to ±1 standard error (dashed lines). The Annals of Thoracic Surgery 2007 84, 444-450DOI: (10.1016/j.athoracsur.2007.03.078) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions